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5.1 Introduction
The expansion of minimally invasive surgery and transcatheter interventions put 
greater meaning on imaging techniques in patient qualification and procedure 
 planning. For better understanding of the anatomy on standard volumetric medical 
images, modern three-dimensional (3D) visualization methods have found to be 
 especially beneficial. They include 3D printing, augmented and virtual reality, or 
advanced rendering techniques, such as cinematic rendering. The major advantages 
of 3D printing above other methods include element of tactility, which makes the 
experience more realistic for the surgeon, and ability to simulate procedures. Having 
said that, there is no strong evidence right now whether there are differences between 
those techniques in terms of clinical outcomes or decision making.
This chapter will introduce basic concepts of 3D printing, overview of methodol-
ogy, and state of the art in current clinical practice. We will put special attention to 
real-life cases where 3D printing is being implemented routinely for preoperative and 
intraoperative decision making. This chapter covers only the main field of clinical 
3D printing, which consists of personalized anatomical models. We will not discuss 
topics related to 3D printed implants, dental 3D printing, or bioprinting.
5.2 Introduction of 3D printing to clinical practice
Although 3D printing has its history reaching back to 1980s and first attempts to use 
it in medicine were in the 1990s and early 2000s (especially in the U.S. military), truly 
clinical 3D printing started in 2008 in Mayo Clinic in Rochester, MN, USA. This case 
and establishing the first clinical 3D printing lab at Mayo’s Department of Radiology 
by Jonathan Morris and Jane Matsumoto in 2013 were the starting points to the great 
expansion of clinical 3D printing [1]. Initial reports and reviews suggested extremely 
high benefits of using the technology and broad range of possible implementations in 
all medical fields [2, 3]. However, just within next few years, researchers have found 
areas that can gain from 3D printing the most and quickly experimented with it. So 
far, orthopedics, maxillofacial surgery, and cardiology have been the fields with most 
3D printed models. Anatomical models and surgical guides are the most common 
types of printouts. These initial reports, though, have helped to move the field forward 
quickly. Special interest groups and working teams within societies were created, with 
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Radiological Society of North America (RSNA) in the front. Currently, it unites several 
hundred medical professionals and researchers working on 3D printing.
It is important to notice that although 3D printing is available for about a decade 
now, clinical evidence is still relatively sparse. The most published research consists 
of case studies, as the personalization of 3D printing comes most useful in rare and 
complex cases. The first meta-analyses have been published very recently, virtu-
ally only in orthopedic surgery [4, 5]. Systematic reviews have been performed for 
most medical fields, however, and have shown that models are accurate and helpful. 
Having said that, those conclusions are drawn usually just from physicians’ reports 
and with no quantitative data to support it. In-hospital 3D printing labs are still 
located in almost only large university hospitals, often with industry support. There is 
a slow change toward more desktop, user-friendly, and accessible machines, and the 
process itself is simplifying, helping the expansion of the technology. It is still most 
likely that smaller, rural hospitals will never need 3D printing services.
5.3 The 3D printing process
There are many definitions for 3D printing. To simplify, it can be described as 
fabricating physical 3D object based on virtual 3D mesh, by successively printing 
layers on top of one another. In medical scenario, “physical 3D object” is usually an 
anatomical model, and “virtual 3D mesh” is a computer representation of anatomical 
structure. The crucial part of clinical 3D printing, however, is the process that leads to 
creating that virtual model based on medical imaging. This process, called segmenta-
tion, has been widely explored in computer vision for decades, which led to partial 
automatization [6]. Several open-source software packages are available to speed up 
segmentation process with access to semiautomatic algorithms, e.g., thresholding or 
region growing. Having said that, segmentation is still considered one of the main 
bottlenecks of 3D visualization and 3D printing processes.
The idea of segmentation is simple: anatomical regions of interests (ROIs) have to 
be annotated (contoured) slice by slice, preferably by an expert in medical imaging. 
Today, it is a common practice in medical 3D printing labs to have a team of engineers 
performing segmentations and have them reviewed and confirmed by experienced 
radiologists. This task, depending on body area and quality of imaging, can take 
 anywhere from 1 min to 5 h. Good examples of more complex cases are as follows: 
 visceral anatomy (hepatic veins, renal vasculature), tumors with heterogenous atten-
uation, and vague borders, nerves, or lymph nodes. Segmented ROIs can be exported 
as “masks” or “labelmaps,” usually in binary format (0, background; 1, area of inter-
est), relative pixelwise to input data. They can also be easily exported straight to 
virtual 3D mesh, usually in .stl or .obj formats, and subsequently displayed—this 
process is called surface rendering. Once the mesh is exported, it—theoretically—is 
ready to be 3D printed. However, some sort of postprocessing is usually performed 
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before sending files to a printer. The most common postprocessing operations are 
making the model hollow, cutting through the model, dividing model into several 
parts, smoothing, and adding identifiers or text onto the mesh. There is a final step 
before the model can be 3D printed. Files with models have to be loaded into the 
software that is handling communication with the printer and “translating the mesh 
language into 3D printer language.” The language of 3D printers (and other CNC 
machines), called G-code, consists of instructions on how to create physical 3D object 
layer by layer. This translation from 3D mesh to G-code is sometimes referred to as 
slicing, and software packages are called slicers. Although for most 3D printers there 
are dedicated, proprietary solutions, some open-source slicers are available. The most 
commonly used currently are Cura (open-source) and Simplify3D (Fig. 5.1). (Note: do 
not confuse slicers with 3D Slicer—popular open-source software for segmentation 
that does not perform slicing for 3D printing.)
Again, physical 3D objects are created by successively printing layers on top of 
one another. There are a number of methods that make it possible; however, they 
usually are based on two ideas: melting hard filaments or solidification of liquid or 
powder. The first method uses filaments (usually polylactic acid [PLA] or acrylonitrile 
Fig. 5.1: Workflow of 3D printing: all phases from image acquisition to printed model. Case of 3D 
printing liver models for preoperative planning, done routinely at Jagiellonian University (Kraków, 
Poland).
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butadiene styrene [ABS]) that are being heated up in printer and disposed layer by 
layer through a nozzle. Filament solidifies just after extrusion as it cools off, forming a 
3D structure. The second approach uses fluids (usually resins) solidified with UV light 
or powder solidified with laser beam. Is it important to know the trade-off between 
all methods. Some of them may not be useful in specific clinical applications (Fig. 5.2, 
Tab. 5.1).
5.4 Clinical example: liver models
Laparoscopic liver surgery is often the treatment of choice for patients with intra-
hepatic malignancies. Those procedures require extensive preoperative workup, 
Fig. 5.2: Model of aortic root 3D printed with stereolithography technique. Semiflexible resin 
allowed the simulation of transcatheter aortic valve implantation (TAVI) and proper valve sizing. 
Model was created in 2017 for cardiologists from Warsaw Medical University (Warsaw, Poland).
Tab. 5.1: Comparison of the most common 3D printing fabrication methods
Fused deposition 
modeling (FDM)
Stereolithography 
(SLA; or DLP)
Selective later 
sintering (SLS)
“PolyJet”/“multicolor 
printing”
Printing 
method
Melting hard 
filaments
Solidifying fluid Solidifying powder Solidifying fluid
Costs Very low Low/medium Medium/high Extremely high
Materials Very limited, 
virtually no flexible 
materials
From tough to 
slightly flexible 
From tough to very 
flexible
From tough to very 
flexible 
Clinical 
potential
Good visualization 
potential, low 
simulation potential
Good visualization 
potential, medium 
simulation potential
Medium visualization 
potential, good 
simulation potential
Very good 
visualization and 
simulation potential
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 including imaging (computed tomography or magnetic resonance) and precise plan-
ning. Understanding 3D relationships between tumors and hepatic vessels is crucial 
in performing safe and effective resections. As laparoscopic hepatectomies are elec-
tive procedures, 3D printing seems perfect as an aid in decision making.
There are approximately 20 studies published in the area of liver surgery [7, 8]. 
Most of them, unfortunately, are case studies or case series. As liver models require 
visualization of multiple structures at once, PolyJet is the fabrication method of 
choice in most cases, although cost-effective approaches are also explored [9]. Our 
research group has also shown that 3D printed liver models are highly accurate [10]. 
A 2019 study by Yang et al. [11] presents that printed models result in the improved 
assessment of tumor location in comparison with MDCT and standard virtual 3D 
reconstruction. They also proved that understanding 3D relationship is easier with 
printed model, as time spent on assessing the tumor location was lowest between all 
groups (93 s in 3D printing group, over 200 s in other two). Unfortunately, no large 
randomized or standard prospective trials have been published yet. Our group is 
running a clinical trial (registered in ClinicalTrials.gov database under NCT03744624 
identifier), which is aimed to recruit approximately 85 patients and end before the 
end of 2022.
Three-dimensional printing in liver surgery is a great example of difficulties 
related to getting strong evidence of clinical benefits. Patient group is very hetero-
genic, and getting statistically significant results requires the recruitment of a large 
number of individuals. Liver models are also more costly and require more work 
than others because they have to be multimaterial and multicolor for full immersion. 
 PolyJet-based liver models can cost up to a few thousand dollars per one model [12]. 
Low-cost methods can reduce this to approximately $150, although they require more 
manpower and time. In oncological patients qualified for resection, these models are 
extremely helpful in choosing the most optimal resection plane and establishing safe 
resection margins. Preoperative decision making can reduce number of alterations 
to surgical plan during complex procedure and may help in finding patients who are 
most exposed to posthepatectomy liver failure. Trial results in coming years should 
answer whether this is the case (Fig. 5.3).
5.5  Clinical example: congenital heart disease and transcatheter 
interventions
Congenital heart disease printed models are one of the most explored and proven 
applications of medical 3D printing. There are a number of studies proving its utility 
and several labs dedicated to work specifically in this area (Fig. 5.4).
In 2018, the RSNA 3D Printing Special Interest Group published their first guide-
lines on clinical use of 3D printing. Guidelines included congenital heart disease, 
craniomaxillofacial, genitourinary, musculoskeletal, vascular, and breast 3D 
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Fig. 5.3: Examples of 3D liver models, developed routinely at Jagiellonian University (Kraków, 
Poland). They are fully personalized, full sized, and multimaterial. Our unique low-cost approach 
allowed to reduce production from approximately $2,000 to $150 per model. Average time from CT 
acquisition to model delivery is 5 days. Transparent parenchyma is made with silicone by casting it 
into a mold printed on a desktop FDM 3D printer.
Fig. 5.4: Fused deposition modeling approach 
allows labs to create personalized models of 
congenital heart diseases with approximately 
24-h turnaround time from image acquisition. This 
fabrication technique was satisfactory here, as 
models are used only for visualization and not for 
simulation. The model in this picture was delivered 
to cardiologists from University Children’s 
Hospital of Kraków.
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models [13]. Appropriateness Guidelines scored medical conditions on a scale from 
1 to 10 (10  being most useful and with strongest clinical evidence). Double outlet 
right  ventricle, truncus arteriosus, and anomalous pulmonary venous connection 
were the conditions found to benefit the most from 3D printing and scored 8 and 
above. Surprisingly, arterial and ventricular septal defects scored very low, between 
2 and 5, although 3D printed models have been proven to be very useful in simu-
lating closure procedures. Flexible models of septal defects can be used to perform 
mock transcatheter procedures and may help in choosing proper device size, improv-
ing the safety of surgery [14]. They help to understand spatial relationships between 
 structures normally seen by cardiologists in echocardiography and learn how to 
proceed with the catheter delivery system. Models for nonvalvular structural heart 
diseases, usually meaning left atrial appendage occlusion, help in choosing the 
proper device, similarly to septal defects. 
At Jagiellonian University, we have created an “atlas” of 3D printed congenital 
heart disease models. Based on real cases and imaging, they show variability within 
a single condition. The atlas can be used for parent and patient education and for 
getting an informed consent. More complex models may also be available for less 
experienced cardiology and cardiac surgery residents for learning complex repair 
procedures. Although structures are relatively small, the resolution of 3D printers is 
high enough to make accurate representations of the anatomy. In addition, models 
can be scaled and divided in any way, providing many possibilities for visualization 
at request. Segmentation can be tricky, as mentioned before, although there is com-
mercial software dedicated for cardiovascular segmentation, e.g., Mimics (Materialise 
NV, Leuven, Belgium), that can make this part as quick as 30 min. Elastic or multima-
terial and multicolor models are preferred, although in our experience even rigid and 
monocolor models are useful. 
Research shows that 3D printed cardiovascular models can be as effective in 
educational setting as cadaveric specimens, offering a way to avoid ethical issues. In 
some cases, they have also been proven to have similar mechanical properties and 
echocardiography visualization [15].
5.6 Creating in-house 3D lab and summary
There are multiple challenges necessary to consider when planning a new 3D print-
ing in-hospital lab. Considering the budget, it is often forgotten that 3D printing is a 
work-consuming process, and it requires engagement of qualified people. Clinicians, 
preferably radiologists, should perform or at least review segmentations before model 
printing. Engineers should be able to properly choose the fabrication method to 
meet physician expectations and have a good insight into hardware. Three-
dimensional printing is still fairly experimental, so it is safe to assume that some 
percentage of prints will either fail or not meet clinical expectations. The location of 
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the lab is important too. To maintain maximum safety by avoiding fumes and fire risk, 
the lab should be well ventilated and separate from the clinical area. It is crucial to 
ask surgeons for intraoperative photo.
In medical 3D printing field, it is now clear that this technology will benefit both 
patients and clinicians. However, it will not be used everywhere and will not dra-
matically change the landscape. It seems that in the future, we will see more focus 
on simulations and preprocedural planning with 3D printing and routine use of it 
in complex cases. Advances in segmentation software and further reduction of costs 
related to 3D printers should automatize the process and make it more accessible to 
smaller institutions, especially outside the United States (Fig. 5.5).
We have not discussed topics related to ethical and legal issues. For example, 
who is the owner of a patient’s data? Do we consider 3D models or printers equipment 
requiring FDA approval? For more information on this, please refer to FDA’s  Technical 
Fig. 5.5: Intraoperative photo of 3D printed facial lesion model with close proximity to facial artery 
and infraorbital nerve. Created with fused deposition modeling approach, was used by plastic 
surgeons in Wrocław, Poland.
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Considerations for Additive Manufactured Medical Devices, which is currently the 
only official guideline from U.S. government bodies regarding medical 3D printing 
[16] as well as James Coburn and Gerald Grant [17] commentary on the FDA process. 
We have also omitted validation and verification issues: there is no standardization 
is this area. The largest 3D printing labs have established their own, internal quality 
assessment protocols. Please refer to a chapter written by Dimitrios Mitsouras, 
 Elizabeth George, and Frank Rybicki [18] to learn more about this. There are also 
strong efforts in several 3D printing working groups, especially RSNA 3DP SIG, 
toward assuring high model accuracy and quality.
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